Martin Samuel Bates's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Aug 12, 2021
- Accession no.
- 0001179110-21-008140
- Filed
- Aug 12, 2021
- Trade date
- Aug 10, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $123.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Martin Samuel BatesCIK 0001709024 | Officer (SVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | MOption exerciseAcquired | +10,302 | $9.02 | +$92,924.04 | 21,037 | Direct | |
| Aug 10, 2021 | Common Stock | SSaleDisposed | −2,056 | $45.25 | −$93,034 | 18,981 | Direct | |
| Aug 10, 2021 | Common Stock | MOption exerciseAcquired | +11,079 | $2.78 | +$30,799.62 | 30,060 | Direct | |
| Aug 10, 2021 | Common Stock | SSaleDisposed | −682 | $45.25 | −$30,860.5 | 29,378 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | MOption exerciseDisposed | −10,302 | $0.00 | $0 | 16,030 | Direct | |
| Aug 10, 2021 | Common Stock | MOption exerciseDisposed | −11,079 | $0.00 | $0 | 31,921 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.